Literature DB >> 26984071

Clinical Search for Undiagnosed Mesenteric Phlebosclerosis at Outpatient Departments Specializing in Herbal (Kampo) Medicine.

Yutaka Nagata1, Tetsuo Watanabe, Kazuhiko Nagasaka, Masaaki Yamada, Minoru Saito, Toshinori Yazaki, Kenichi Komatsu, Mika Sano, Koji Asano, Chikao Ando, Norihide Taniuchi.   

Abstract

OBJECTIVE: Mesenteric phlebosclerosis (MP) is a disease characterized by calcification of the mesenteric vein, which causes chronic mesenteric ischemia. Recently, the long-term intake of gardenia fruit ('Sanshishi' in Japanese) has been attracting attention as a possible cause. Usually, only advanced, severe MP cases get reported. However, we suspected that some latent cases of this disease may exist. We performed this study in order to determine the prediagnostic cases at our outpatient departments of herbal (Kampo) medicine, with particular attention paid to the initial changes, such as any slight color change of the colon, as shown in colonoscopy.
METHODS: We recommend colonoscopy and computed tomography (CT) scans for patients with a long-term history of taking herbal medicines containing gardenia fruit. Clinical examinations were performed upon receiving patients' consent from December 2013 to November 2014.
RESULTS: Of the 103 patients who took gardenia fruit long-term, 29 agreed to be checked for MP. 14 patients underwent colonoscopy. Four patients were confirmed to have MP due to the presence of fibrotic deposition of the colonic membrane on histological inspection. Twenty-one patients underwent abdominal CT screening. Characteristic calcification of the mesenteric vein was observed on CT scans in 2 patients. All 4 MP patients took Kampo formulas containing gardenia fruit for more than 6.8 years. The other patients did not develop MP, despite long-term gardenia fruit intake.
CONCLUSION: We detected the latent and undiagnosed MP cases. All diagnoses were made while paying careful attention to any slight changes in colonoscopy and CT scans.

Entities:  

Mesh:

Year:  2016        PMID: 26984071     DOI: 10.2169/internalmedicine.55.5642

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  6 in total

1.  Idiopathic mesenteric phlebosclerosis: one case report and systematic literature review of 240 cases.

Authors:  Jialiang Wang; Jun Shao; Helei Lu; Bingyi Wang; Ji Chen
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

2.  Total dosage of gardenia fruit used by patients with mesenteric phlebosclerosis.

Authors:  Yutaka Nagata; Tetsuo Watanabe; Kazuhiko Nagasaka; Masaaki Yamada; Masafumi Murai; Sunao Takeuchi; Mai Murase; Toshinori Yazaki; Takayuki Murase; Kenichi Komatsu; Machiko Kaizuka; Mika Sano; Koji Asano; Chikao Ando; Norihide Taniuchi
Journal:  BMC Complement Altern Med       Date:  2016-07-11       Impact factor: 3.659

3.  Possibility of Interstitial Lung Disease as a Phlebosclerotic Colitis Manifestation.

Authors:  Tomoyasu Takemura; Yuki Kataoka; Reika Iki; Yasuyuki Nishioka; Naoko Matsubara; Mitsunori Kanagaki; Yoshitomo Yasumizu
Journal:  Case Rep Gastroenterol       Date:  2018-04-24

4.  Adverse Events Associated with Ethical Kampo Formulations: Analysis of the Domestic Adverse-Event Data Reports of the Ministry of Health, Labor, and Welfare in Japan.

Authors:  Yutaka Shimada; Makoto Fujimoto; Tatsuya Nogami; Hidetoshi Watari
Journal:  Evid Based Complement Alternat Med       Date:  2019-04-15       Impact factor: 2.629

5.  Effectiveness and safety of Hwangryunhaedok-Tang (Huang-Lian-Jie-Du-Tang, Oren-Gedoku-to) for dyslipidemia: A protocol for a PRISMA-compliant systematic review and meta-analysis.

Authors:  Boram Lee; Chan-Young Kwon
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

6.  Phosphoglyceride crystal deposition disease involving adnexa uteri: a case report with histogenetic consideration.

Authors:  Toshitsugu Nakamura; Masayuki Fujiwara; Kikue Hara; Kazuko Kurosawa; Tatsuhiko Miyazaki
Journal:  Pathologica       Date:  2021-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.